NFKB1 and neoplasm: The anti-tumor activity of chrysin is mediated through direct action on multiple molecular targets and modulation of signal transduction of different inflammatory pathways (NFkB, p38/MAPK TBK1, Wnt/β-catenin) and cellular metabolism pathways (AMPK/AKT/ERK/PPAR) [63,64,65,66].